- Home
- GRFS vs FLY Comparison
GRFS vs FLY Comparison
Compare GRFS & FLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRFS
- FLY
- Stock Information
- Founded
- GRFS 1940
- FLY 2017
- Country
- GRFS Spain
- FLY United States
- Employees
- GRFS N/A
- FLY N/A
- Industry
- GRFS Biotechnology: Pharmaceutical Preparations
- FLY Military/Government/Technical
- Sector
- GRFS Health Care
- FLY Industrials
- Exchange
- GRFS Nasdaq
- FLY Nasdaq
- Market Cap
- GRFS 7.2B
- FLY 7.1B
- IPO Year
- GRFS 2006
- FLY 2025
- Fundamental
- Price
- GRFS $10.72
- FLY $47.34
- Analyst Decision
- GRFS Hold
- FLY
- Analyst Count
- GRFS 1
- FLY 0
- Target Price
- GRFS $10.30
- FLY N/A
- AVG Volume (30 Days)
- GRFS 1.3M
- FLY 7.2M
- Earning Date
- GRFS 01-01-0001
- FLY 01-01-0001
- Dividend Yield
- GRFS 1.33%
- FLY N/A
- EPS Growth
- GRFS 132.60
- FLY N/A
- EPS
- GRFS 0.53
- FLY N/A
- Revenue
- GRFS $8,744,226,659.00
- FLY $108,330,000.00
- Revenue This Year
- GRFS $5.40
- FLY N/A
- Revenue Next Year
- GRFS $6.74
- FLY N/A
- P/E Ratio
- GRFS $25.84
- FLY N/A
- Revenue Growth
- GRFS 9.32
- FLY 10.06
- 52 Week Low
- GRFS $6.19
- FLY $46.31
- 52 Week High
- GRFS $11.14
- FLY $73.80
- Technical
- Relative Strength Index (RSI)
- GRFS 66.35
- FLY N/A
- Support Level
- GRFS $10.40
- FLY N/A
- Resistance Level
- GRFS $10.84
- FLY N/A
- Average True Range (ATR)
- GRFS 0.32
- FLY 0.00
- MACD
- GRFS -0.04
- FLY 0.00
- Stochastic Oscillator
- GRFS 73.91
- FLY 0.00
About GRFS Grifols S.A.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.